# Claritev Corp: overview

CTEV · NYSE · CIK 1793229 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctev.md) · [Financials](/companies/ctev/financials.md) · [Filings](/companies/ctev/filings.md) · [Insiders](/companies/ctev/insiders.md)

Latest reported revenue: [$257.5m](/filings/0001793229-26-000067.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001793229-26-000067).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [230](/filings/0001793229-25-000170.md) | [232 d](/filings/0001793229-26-000017.md) | [231](/filings/0001793229-26-000046.md) | [242](/filings/0001793229-26-000067.md) | [246](/filings/0001793229-25-000170.md) | [247 d](/filings/0001793229-26-000017.md) | [245](/filings/0001793229-26-000046.md) | [257](/filings/0001793229-26-000067.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(146.7%)](/filings/0001793229-25-000170.md) | [(17.8%) d](/filings/0001793229-26-000017.md) | [4.2%](/filings/0001793229-26-000046.md) | [6.9%](/filings/0001793229-26-000067.md) | [4.1%](/filings/0001793229-25-000170.md) | [(3.1%) d](/filings/0001793229-26-000017.md) | [2.7%](/filings/0001793229-26-000046.md) | [9.1%](/filings/0001793229-26-000067.md) |
| Net margin | % | [(169.8%)](/filings/0001793229-25-000170.md) | [(59.4%) d](/filings/0001793229-26-000017.md) | [(30.8%)](/filings/0001793229-26-000046.md) | [(25.9%)](/filings/0001793229-26-000067.md) | [(28.4%)](/filings/0001793229-25-000170.md) | [(32.7%) d](/filings/0001793229-26-000017.md) | [(30.1%)](/filings/0001793229-26-000046.md) | [(23.0%)](/filings/0001793229-26-000067.md) |
| Diluted EPS | $ per share | [(24.25)](/filings/0001793229-25-000170.md) | not reported | [(4.38)](/filings/0001793229-26-000046.md) | [(3.81)](/filings/0001793229-26-000067.md) | [(4.23)](/filings/0001793229-25-000170.md) | not reported | [(4.41)](/filings/0001793229-26-000046.md) | [(3.49)](/filings/0001793229-26-000067.md) |
| Free cash flow | $m | [41.1 d](/filings/0001793229-25-000170.md) | [(63.8) d](/filings/0001793229-26-000017.md) | [(68.9)](/filings/0001793229-26-000046.md) | [36.6 d](/filings/0001793229-26-000067.md) | [(16.3) d](/filings/0001793229-25-000170.md) | [36.4 d](/filings/0001793229-26-000017.md) | [(92.5)](/filings/0001793229-26-000046.md) | [54.6 d](/filings/0001793229-26-000067.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,118](/filings/0001793229-24-000012.md) | [1,080](/filings/0001793229-24-000012.md) | [962](/filings/0001793229-26-000017.md) | [931](/filings/0001793229-26-000017.md) | [965](/filings/0001793229-26-000017.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [34.5%](/filings/0001793229-24-000012.md) | [(33.6%)](/filings/0001793229-24-000012.md) | [16.8%](/filings/0001793229-26-000017.md) | [(149.4%)](/filings/0001793229-26-000017.md) | [3.0%](/filings/0001793229-26-000017.md) |
| Net margin | % | [9.1%](/filings/0001793229-24-000012.md) | [(53.1%)](/filings/0001793229-24-000012.md) | [(9.5%)](/filings/0001793229-26-000017.md) | [(176.9%)](/filings/0001793229-26-000017.md) | [(29.4%)](/filings/0001793229-26-000017.md) |
| Diluted EPS | $ per share | [0.16](/filings/0001793229-24-000012.md) | [(0.90)](/filings/0001793229-24-000012.md) | [(5.69)](/filings/0001793229-26-000017.md) | [(101.92)](/filings/0001793229-26-000017.md) | [(17.30)](/filings/0001793229-26-000017.md) |
| Free cash flow | $m | [320](/filings/0001793229-24-000012.md) | [283](/filings/0001793229-24-000012.md) | [62.9](/filings/0001793229-26-000017.md) | [(10.5)](/filings/0001793229-26-000017.md) | [(12.3)](/filings/0001793229-26-000017.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ctev/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Ares Management LLC](/insiders/1259313.md) | 10% owner | Purchase (P) | 20,834 | $24.0696 | $501.5k | [Form 4](/filings/0001104659-26-119177.md) |
| 2026-10-26 | [Ares Management LLC](/insiders/1259313.md) | 10% owner | Purchase (P) | 20,834 | $24.0696 | $501.5k | [Form 4](/filings/0001104659-26-119180.md) |
| 2026-10-23 | [Ares Management LLC](/insiders/1259313.md) | 10% owner | Purchase (P) | 50,000 | $23.5328 | $1.2m | [Form 4](/filings/0001104659-26-119177.md) |
| 2026-10-23 | [Ares Management LLC](/insiders/1259313.md) | 10% owner | Purchase (P) | 50,000 | $23.5328 | $1.2m | [Form 4](/filings/0001104659-26-119180.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [H&F Corporate Investors VIII, Ltd.](/funds/1767563.md) | 2026-06-30 | $132.6m | 3,887,858 |  | Unchanged |
| [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $63.6m | 1,863,105 |  | Unchanged |
| [Arini Capital Management Ltd](/funds/2056819.md) | 2026-06-30 | $52.3m | 1,534,687 |  | Unchanged |
| [Arini Capital Management Ltd](/funds/2056819.md) | 2026-06-30 | $52.3m | 1,534,687 |  | Unchanged |
| [PUBLIC INVESTMENT FUND](/funds/1767640.md) | 2026-06-30 | $43.7m | 1,281,250 |  | Unchanged |
| [Beach Point Capital Management LP](/funds/1453885.md) | 2026-06-30 | $26.3m | 770,612 |  | Reduced −24,734 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $24.7m | 723,217 |  | Added +135,214 |
| [CPV Partners, LLC](/funds/1763844.md) | 2026-06-30 | $16.9m | 495,258 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.4m | 423,039 |  | Reduced −7,029 |
| [PRUDENTIAL FINANCIAL INC](/funds/1137774.md) | 2026-06-30 | $12.1m | 353,904 |  | Added +160 |

## Recent filings

[All 532 filings](/companies/ctev/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 09:03 ET | [8-K](/filings/0001793229-26-000077.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001793229-26-000077 |
| 2026-09-15 | 09:07 ET | [8-K](/filings/0001793229-26-000071.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001793229-26-000071 |
| 2026-08-07 | 16:02 ET | [10-Q](/filings/0001793229-26-000067.md) | Quarterly report, period 2026-06-30 | 0001793229-26-000067 |
| 2026-08-07 | 06:00 ET | [8-K](/filings/0001793229-26-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001793229-26-000065 |
| 2026-07-06 | 16:11 ET | [8-K](/filings/0001793229-26-000061.md) | 8.01 Other events | 0001793229-26-000061 |
| 2026-06-22 | 16:01 ET | [8-K](/filings/0001793229-26-000056.md) | 7.01 Regulation FD disclosure | 0001793229-26-000056 |
| 2026-05-18 | 12:00 ET | [8-K](/filings/0001793229-26-000052.md) | 7.01 Regulation FD disclosure | 0001793229-26-000052 |
| 2026-05-07 | 16:09 ET | [10-Q](/filings/0001793229-26-000046.md) | Quarterly report, period 2026-03-31 | 0001793229-26-000046 |
| 2026-05-07 | 06:06 ET | [8-K](/filings/0001793229-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001793229-26-000041 |
| 2026-04-30 | 16:06 ET | [8-K](/filings/0001793229-26-000034.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001793229-26-000034 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001793229-26-000017.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9bf25547-f298-46f9-a7c7-10c63040f3f7)

## About the filer

- CIK: 1793229
- Tickers: CTEV
- Exchange: NYSE
- SIC code: 7389 Services-Business Services, NEC
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:33 ET. No prices; not investment advice.